Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Adebrelimab Combined With Chemotherapy in Locally Advanced Cervical Cancer
NCT07811375Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Oct 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 2 trial of adebrelimab in Cervical Cancer (CC), sponsored by The First Affiliated Hospital of USTC. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
adebrelimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07811375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07811375.